Supraventricular tachycardia AHA recommendations for Management of Asymptomatic Patients With Pre-Excitation
|
Supraventricular tachycardia Microchapters |
|
Differentiating Among the Different Types of Supraventricular Tachycardia |
|---|
|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
|
Diagnosis |
|
Treatment |
|
2015 ACC/AHA Guideline Recommendations |
|
Case Studies |
|
Supraventricular tachycardia AHA recommendations for Management of Asymptomatic Patients With Pre-Excitation On the Web |
|
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of Asymptomatic Patients With Pre-Excitation |
|
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
In asymptomatic patients with pre-excitation, the findings of abrupt loss of conduction over a manifest pathway during exercise testing in sinus rhythm or intermittent loss of pre-excitation during ECG or ambulatory monitoring are useful to identify patients at low risk of rapid conduction over the pathway. An EP study is reasonable in asymptomatic patients with pre-excitation to risk-stratify for arrhythmic events. Catheter ablation of the accessory pathway is reasonable in asymptomatic patients with pre-excitation if an EP study identifies a high risk of arrhythmic events, including rapidly conducting pre-excited AF.[1]
Management of Asymptomatic Patients With Pre-Excitation
2015 AHA recommendations for the management of asymptomatic patients with pre-excitation are described below:[1]
| Class I |
| "1. In asymptomatic patients with pre-excitation, the findings of abrupt loss of conduction over a manifest pathway during exercise testing in sinus rhythm "(Level of Evidence: B_R ) " or intermittent loss of pre-excitation during ECG or ambulatory monitoring (Level of Evidence:C-LD ) " are useful to identify patients at low risk of rapid conduction over the pathway. |
| Class IIa |
| "1. An EP study is reasonable in asymptomatic patients with pre-excitation to risk-stratify for arrhythmic events"(Level of Evidence: B-NR ) " |
| "2. Catheter ablation of the accessory pathway is reasonable in asymptomatic patients with pre-excitation if an EP study identifies a high risk of arrhythmic events, including rapidly conducting pre-excited AF ("(Level of Evidence:B-NR ) " |
| "3. Catheter ablation of the accessory pathway is reasonable in asymptomatic patients if the presence of pre-excitation precludes specific employment (such as with pilots) "(Level of Evidence:B-NR ) " |
| "4. Observation, without further evaluation or treatment, is reasonable in asymptomatic patients with pre-excitation "(Level of Evidence:B-NR ) " |
References
- ↑ 1.0 1.1 Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ; et al. (2016). "2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society". J Am Coll Cardiol. 67 (13): e27–e115. doi:10.1016/j.jacc.2015.08.856. PMID 26409259.